TY - JOUR
T1 - Chapter 19 Methods to Monitor Chaperone-Mediated Autophagy
AU - Kaushik, Susmita
AU - Cuervo, Ana Maria
N1 - Funding Information:
Work in our laboratory is supported by grants from the National Institute of Health AG021904, AG031782, and DK041918, and by a Glenn Award.
PY - 2009
Y1 - 2009
N2 - Chaperone-mediated autophagy (CMA) is a selective type of autophagy responsible for the lysosomal degradation of soluble cytosolic proteins. In contrast to other forms of autophagy where cargo is sequestered and delivered to lysosomes through membrane fusion/excision, CMA substrates reach the lysosomal lumen after direct translocation across the lysosomal membrane. CMA is part of the cellular quality control systems and as such, essential for the cellular response to stress. CMA activity decreases with age, likely contributing to the accumulation of altered proteins characteristic in tissues from old organisms. Furthermore, impairment of CMA underlies the pathogenesis of certain human pathologies such as neurodegenerative disorders. These findings have drawn renewed attention to CMA and a growing interest in the measurement of changes in CMA activity under different physiological and pathological conditions. In this chapter we review the different experimental approaches used to assess CMA activity both in cells in culture and in different organs from animals.
AB - Chaperone-mediated autophagy (CMA) is a selective type of autophagy responsible for the lysosomal degradation of soluble cytosolic proteins. In contrast to other forms of autophagy where cargo is sequestered and delivered to lysosomes through membrane fusion/excision, CMA substrates reach the lysosomal lumen after direct translocation across the lysosomal membrane. CMA is part of the cellular quality control systems and as such, essential for the cellular response to stress. CMA activity decreases with age, likely contributing to the accumulation of altered proteins characteristic in tissues from old organisms. Furthermore, impairment of CMA underlies the pathogenesis of certain human pathologies such as neurodegenerative disorders. These findings have drawn renewed attention to CMA and a growing interest in the measurement of changes in CMA activity under different physiological and pathological conditions. In this chapter we review the different experimental approaches used to assess CMA activity both in cells in culture and in different organs from animals.
UR - http://www.scopus.com/inward/record.url?scp=59249090846&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=59249090846&partnerID=8YFLogxK
U2 - 10.1016/S0076-6879(08)03619-7
DO - 10.1016/S0076-6879(08)03619-7
M3 - Review article
C2 - 19200890
AN - SCOPUS:59249090846
SN - 0076-6879
VL - 451
SP - 297
EP - 324
JO - Methods in Enzymology
JF - Methods in Enzymology
IS - C
ER -